Bargellini, Irene
 Distribuzione geografica
Continente #
NA - Nord America 53
EU - Europa 37
AS - Asia 11
Totale 101
Nazione #
US - Stati Uniti d'America 53
IE - Irlanda 12
IT - Italia 12
SG - Singapore 6
SE - Svezia 5
RU - Federazione Russa 4
CN - Cina 3
FI - Finlandia 2
IN - India 2
DE - Germania 1
NL - Olanda 1
Totale 101
Città #
Ashburn 18
New York 16
Dublin 12
Milan 8
Singapore 5
Rome 4
Moscow 3
Beijing 2
Helsinki 2
Los Angeles 2
Pune 2
Washington 2
Amsterdam 1
Nuremberg 1
Totale 78
Nome #
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression 19
Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial 17
Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial 15
Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib 15
Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial 14
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib 13
Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial 10
Optimised Tumour Sampling and Processing by a Multidisciplinary Approach for an Accurate Diagnosis in Non-Small Cell Lung Cancer 6
Totale 109
Categoria #
all - tutte 1.074
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.074


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202318 0 0 0 0 0 0 4 2 6 4 1 1
2023/202482 0 16 5 7 5 27 9 0 1 2 3 7
2024/20259 8 1 0 0 0 0 0 0 0 0 0 0
Totale 109